ARCH Venture Fund XII, L.P., 10% Owner at Neumora Therapeutics, Inc. (NMRA), bought 66,663 shares at $11.98 ($784K) on 2023-11-14, disclosed to the SEC on 2023-11-15.
Open-market purchase of $784k NMRA by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.75 | 31,653 | $372K | 47.4% |
| 2 | $11.75 | 31,653 | $372K | 47.4% |
| 3 | $11.98 | 3,357 | $40K | 5.1% |
| Total | $11.76 avg | 66,663 | $784K | 100% |
| Filing → |